Literature DB >> 8077232

Inhibition of lectin-mediated ovarian tumor cell adhesion by sugar analogs.

B Woynarowska1, D M Skrincosky, A Haag, M Sharma, K Matta, R J Bernacki.   

Abstract

Adhesion of A-121 human ovarian carcinoma cells to extracellular matrix is partly mediated via interaction between galaptin, an endogenous beta-galactoside-binding lectin present in extracellular matrix, and specific cell surface carbohydrate receptors identified as lysosomal associated membrane proteins, lamp-1 and lamp-2. In this study, we report that adhesion of human ovarian carcinoma cells to polystyrene plates coated with polymerized human splenic galaptin can be inhibited by polyclonal antibodies raised against lamp-1 and lamp-2 molecules and by pretreatment of A-121 human ovarian carcinoma cells with glucosamine analogs: 2-acetamido-1,4,6-tri-O-acetyl-3- deoxy-3-fluoro-alpha-D-glucopyranose (3-F-GlcNAc) and 2-acetamido-1,3,6-tri-O-acetyl-4-deoxy-4-fluoro-alpha-D-glucopyranose (4-F-GlcNAc). A 48-h exposure of A-121 cells to individual sugar analogs, or to a combination of the two, resulted in a concentration-dependent inhibition of cellular attachment to polymerized galaptin. Both drugs inhibited glycoprotein biosynthesis as measured by cellular incorporation of labeled [3H]glucosamine and [3H]fucose with negligible effects on [3H]thymidine and [3H]leucine incorporation and cell growth. As a result of drug action on glycoprotein biosynthesis, an alteration in the structure of the galaptin receptor was noted by indirect immunofluorescence and Western blot analysis. Moreover, probing gels of cell extracts with anti-lamp antibodies or Datura stramonium lectin demonstrated significant changes in the reactivity and pattern of glycoprotein staining, suggesting an effect of sugar analogs on the glycosylation of various cellular receptor molecules. The greatest change was observed when tumor cells were exposed to a combination of the two sugar analogs. These studies suggest that specific endogenous lectins and their surface receptors play a role in tumor cell adhesion and perhaps metastasis and may serve as suitable targets for therapeutic exploitation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077232

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  Galectin-1 research in T cell immunity: past, present and future.

Authors:  Filiberto Cedeno-Laurent; Charles J Dimitroff
Journal:  Clin Immunol       Date:  2011-10-06       Impact factor: 3.969

2.  Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoro-glucosamine analogue.

Authors:  B Woynarowska; C J Dimitroff; M Sharma; K L Matta; R J Bernacki
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

3.  Fluorinated per-acetylated GalNAc metabolically alters glycan structures on leukocyte PSGL-1 and reduces cell binding to selectins.

Authors:  Dhananjay D Marathe; Alexander Buffone; E V Chandrasekaran; Jun Xue; Robert D Locke; Mehrab Nasirikenari; Joseph T Y Lau; Khushi L Matta; Sriram Neelamegham
Journal:  Blood       Date:  2009-12-08       Impact factor: 22.113

4.  Metabolic inhibition of galectin-1-binding carbohydrates accentuates antitumor immunity.

Authors:  Filiberto Cedeno-Laurent; Matthew J Opperman; Steven R Barthel; Danielle Hays; Tobias Schatton; Qian Zhan; Xiaoying He; Khushi L Matta; Jeffrey G Supko; Markus H Frank; George F Murphy; Charles J Dimitroff
Journal:  J Invest Dermatol       Date:  2011-12-08       Impact factor: 8.551

5.  Inhibition of colony formation in agarose of metastatic human breast carcinoma and melanoma cells by synthetic glycoamine analogs.

Authors:  G V Glinsky; V V Mossine; J E Price; D Bielenberg; V V Glinsky; H N Ananthaswamy; M S Feather
Journal:  Clin Exp Metastasis       Date:  1996-05       Impact factor: 5.150

Review 6.  Galectins and their ligands: negative regulators of anti-tumor immunity.

Authors:  Filiberto Cedeno-Laurent; Charles J Dimitroff
Journal:  Glycoconj J       Date:  2012-04-29       Impact factor: 2.916

Review 7.  Leveraging fluorinated glucosamine action to boost antitumor immunity.

Authors:  Charles J Dimitroff
Journal:  Curr Opin Immunol       Date:  2012-12-06       Impact factor: 7.486

8.  Galectin-3 in urine of cancer patients: stage and tissue specificity.

Authors:  Kiruthika Balasubramanian; Raghavendra Vasudevamurthy; Sathisha Upparahalli Venkateshaiah; Anil Thomas; A Vishweshwara; Shylaja Mallaiah Dharmesh
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-03       Impact factor: 4.553

9.  The human endometrium expresses the glycoprotein mucin-1 and shows positive correlation for Thomsen-Friedenreich epitope expression and galectin-1 binding.

Authors:  Udo Jeschke; Hermann Walzel; Ioannis Mylonas; Panos Papadopoulos; Naim Shabani; Christina Kuhn; Sandra Schulze; Klaus Friese; Uwe Karsten; David Anz; Markus S Kupka
Journal:  J Histochem Cytochem       Date:  2009-06-08       Impact factor: 2.479

10.  Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen.

Authors:  Charles J Dimitroff; Thomas S Kupper; Robert Sackstein
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.